Therapeutic plasma exchange as bridging therapy for carbimazole-induced cholestatic hepatitis in a thyrotoxic patient
Asian Journal of Internal Medicine · 10.03.2026 · 5 (1) · 100-105
DOI: 10.4038/ajim.v5i1.367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Internal Medicine, online erschienen am 10.03.2026. Verfasst von P. Karunathilake und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carbimazole, a widely used thionamide, is usually well tolerated but can rarely cause severe cholestatic hepatitis. We report a 43-year-old woman on carbimazole for newly diagnosed hyperthyroidism two months back, who presented with a history of fever for 12 days, associated with abdominal pain, pruritus, dark urine, and jaundice. Examination showed features of thyrotoxicosis with cholestatic jaundice. Investigations revealed marked hyperbilirubinaemia with raised alkaline phosphatase and gamma-glutamyl transferase, and persistently high free T4/T3 levels. Imaging excluded biliary obstruction. Screening for viral and autoimmune hepatitis was negative. Carbimazole was discontinued immediately. The patient received propranolol, ursodeoxycholic acid, lithium carbonate, intravenous hydrocortisone, and supportive care. Three therapeutic plasma-exchange sessions were performed, which led to clinical and biochemical improvement. She was commenced on levothyroxine following total thyroidectomy. Follow-up confirmed complete resolution of jaundice and normalisation of liver function. This case highlights that early recognition of carbimazole-induced liver injury is crucial, and plasma exchange can be an effective bridge to definitive treatment.
Zitieren
APA
Karunathilake, P., Kumarihamy, P., Bowatte, S., Medagedara, D., Ileperuma, M., Wijesinghe, C., Maleeha, M. A. F., & Jayasinghe, S. (2026). Therapeutic plasma exchange as bridging therapy for carbimazole-induced cholestatic hepatitis in a thyrotoxic patient. Asian Journal of Internal Medicine, 5(1), 100-105. https://doi.org/10.4038/ajim.v5i1.367
Vancouver
Karunathilake P, Kumarihamy P, Bowatte S, Medagedara D, Ileperuma M, Wijesinghe C, et al. Therapeutic plasma exchange as bridging therapy for carbimazole-induced cholestatic hepatitis in a thyrotoxic patient. Asian Journal of Internal Medicine. 2026;5(1):100-105. doi:10.4038/ajim.v5i1.367
BibTeX
@article{Karunathilake2026,
author = {Karunathilake, P. and Kumarihamy, P. and Bowatte, S. and Medagedara, D. and Ileperuma, M. and Wijesinghe, C. and Maleeha, M. A. F. and Jayasinghe, S.},
title = {Therapeutic plasma exchange as bridging therapy for carbimazole-induced cholestatic hepatitis in a thyrotoxic patient},
journal = {Asian Journal of Internal Medicine},
year = {2026},
volume = {5},
number = {1},
pages = {100--105},
doi = {10.4038/ajim.v5i1.367}
}
EUVIMED